Evidence map›Paper›PMID 36855162›Full record

ArticleAlzheimer's research & therapy2023

Disruption of early visual processing in amyloid-positive healthy individuals and mild cognitive impairment.

Daniel C Javitt, Antigona Martinez, Pejman Sehatpour, Anna Beloborodova, Christian Habeck, Yunglin Gazes, Dalton Bermudez, Qolamreza R Razlighi, D P Devanand, Yaakov Stern

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's research & therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Alzheimer's disease pathophysiology in the Retina.Progress in retinal and eye research · 2024
    Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Daniel C JavittDivision of Experimental Therapeutics, Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, Unit 21, New York, NY, 10032, USA. dcj2113@cumc.columbia.edu.
Antigona MartinezDivision of Experimental Therapeutics, Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, Unit 21, New York, NY, 10032, USA.
Pejman SehatpourDivision of Experimental Therapeutics, Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, Unit 21, New York, NY, 10032, USA.
Anna BeloborodovaDivision of Experimental Therapeutics, Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, Unit 21, New York, NY, 10032, USA.
Christian HabeckCognitive Neuroscience Division, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, 10032, USA.
Yunglin GazesCognitive Neuroscience Division, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, 10032, USA.
Dalton BermudezDivision of Schizophrenia Research, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, 10962, USA.
Qolamreza R RazlighiQuantitative Neuroimaging Laboratory, Department of Radiology, Weill Cornell Medicine, Brain Health Image Institute, New York, NY, 10065, USA.
D P DevanandArea Brain Aging and Mental Health, Columbia University Irving Medical Center/New York State Psychiatric Institute, New York, NY, 10032, USA.
Yaakov SternCognitive Neuroscience Division, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, 10032, USA.
Columbia University · USNathan Kline Institute for Psychiatric Research · USColumbia University Irving Medical Center · USWeill Cornell Medicine · US

Funding

Exploring Cognitive Aging Using Reference Ability Neural NetworksR01AG038465 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HABECK, CHRISTIAN GEORG, STERN, YAAKOV · 2011 to 2025
$17.0M
Imaging of Cognition, Learning and Memory in AgingR01AG026158 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI STERN, YAAKOV · 2004 to 2021
$10.9M
EARLY CORTICAL PROCESSING IN SCHIZOPHRENIAR01MH049334 · NIMH · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI JAVITT, DANIEL C. · 1998 to 2022
$8.8M
Olfactory deficits and donepezil treatment in cognitively impaired elderlyR01AG041795 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DEVANAND, DAVANGERE P · 2013 to 2017
$3.2M
NIA NIH HHS R01 AG026158NIA NIH HHS R01 AG038465NIA NIH HHS R01 AG041795NIH HHS R01-AG026158NIH HHS R01 AG041795NIMH NIH HHS R01 MH049334
6 · The paper itself

Abstract

backgroundAmyloid deposition is a primary predictor of Alzheimer's disease (AD) and related neurodegenerative disorders. Retinal changes involving the structure and function of the ganglion cell layer are increasingly documented in both established and prodromal AD. Visual event-related potentials (vERP) are sensitive to dysfunction in the magno- and parvocellular visual systems, which originate within the retinal ganglion cell layer. The present study evaluates vERP as a function of amyloid deposition in aging, and in mild cognitive impairment (MCI).

methodsvERP to stimulus-onset, motion-onset, and alpha-frequency steady-state (ssVEP) stimuli were obtained from 16 amyloid-positive and 41 amyloid-negative healthy elders and 15 MCI individuals and analyzed using time-frequency approaches. Social cognition was assessed in a subset of individuals using The Awareness of Social Inference Test (TASIT).

resultsNeurocognitively intact but amyloid-positive participants and MCI individuals showed significant deficits in stimulus-onset (theta) and motion-onset (delta) vERP generation relative to amyloid-negative participants (all p < .01). Across healthy elders, a composite index of these measures correlated highly (r =  - .52, p < .001) with amyloid standardized uptake value ratios (SUVR) and TASIT performance. A composite index composed of vERP measures significant differentiated amyloid-positive and amyloid-negative groups with an overall classification accuracy of > 70%. DISCUSSION: vERP may assist in the early detection of amyloid deposition among older individuals without observable neurocognitive impairments and in linking previously documented retinal deficits in both prodromal AD and MCI to behavioral impairments in social cognition.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAgedAgingAmyloidogenic ProteinsHumansRetinaVisual PerceptionAmyloidogenic ProteinsAlzheimer’s diseaseAmyloidEvent-related potentialsOscillationsVisual processing

Identifiers

PMID36855162
PMCPMC9972790
OpenAlexW4322720277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.